Access to Recombinant Erythropoietin by Medicare-Entitled Dialysis Patients in the First Year After FDA Approval
Powe, Neil R.
Griffiths, Robert I.
de Lissovoy, Gregory
Anderson, Gerard F.
Watson, Alan J.
Greer, Joel W.
Herbert, Robert J.
Eggers, Paul W.
Milam, Roger A.
Whelton, Paul K.
JAMA. 1992 Sep 16; 268(11): 1434-1440.
Age Factors; Biomedical Technologies; Disease; Drugs; Economics; Evaluation; Evaluation Studies; Federal Government; Females; Financial Support; Government; Health; Health Facilities; Health Insurance; Home Care; Insurance; Males; Patient Care; Patients; Proprietary Health Facilities; Selection for Treatment; Socioeconomic Factors;
Showing items related by title, author, creator and subject.
Access to Recombinant Erythropoietin by Medicare-Entitled Dialysis Patients in the First Year After FDA Approval Powe, Neil R.; Griffiths, Robert I.; de Lissovoy, Gregory; Anderson, Gerard F. (1992-09-16)